Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 2
2008 3
2009 5
2010 7
2011 4
2012 4
2013 4
2014 5
2015 4
2016 4
2017 4
2018 3
2019 4
2020 5
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result.
Morote J, Celma A, Diaz F, Regis L, Roche S, Mast R, Semidey ME, de Torres IM, Planas J, Trilla E. Morote J, et al. Among authors: planas j. Urol Oncol. 2020 May;38(5):410-417. doi: 10.1016/j.urolonc.2019.12.013. Epub 2020 Feb 15. Urol Oncol. 2020. PMID: 32067845
How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies.
Borque-Fernando Á, Esteban LM, Celma A, Roche S, Planas J, Regis L, de Torres I, Semidey ME, Trilla E, Morote J. Borque-Fernando Á, et al. Among authors: planas j. World J Urol. 2020 Jun;38(6):1481-1491. doi: 10.1007/s00345-019-02946-w. Epub 2019 Sep 10. World J Urol. 2020. PMID: 31506748
Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings.
Morote J, Schwartzman I, Borque A, Esteban LM, Celma A, Roche S, de Torres IM, Mast R, Semidey ME, Regis L, Santamaría A, Planas J, Trilla E. Morote J, et al. Among authors: planas j. Urol Oncol. 2020 Nov 4:S1078-1439(20)30488-9. doi: 10.1016/j.urolonc.2020.10.016. Online ahead of print. Urol Oncol. 2020. PMID: 33160846
Re: Lars Boesen, Nis Nørgaard, Vibeke Løgager, et al. Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men. Eur Urol Oncol 2019;2:311-9.
Morote J, Celma A, Planas J. Morote J, et al. Among authors: planas j. Eur Urol Oncol. 2020 Jun;3(3):392-393. doi: 10.1016/j.euo.2019.08.009. Epub 2019 Oct 16. Eur Urol Oncol. 2020. PMID: 31628008 No abstract available.
The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?
Regis L, Celma A, Planas J, Lopez R, Roche S, Lorente D, Placer J, Trilla E, Morote J. Regis L, et al. Among authors: planas j. Scand J Urol. 2019 Feb;53(1):21-25. doi: 10.1080/21681805.2018.1551243. Epub 2019 Jan 10. Scand J Urol. 2019. PMID: 30628520
Role of immunotherapy in castration-resistant prostate cancer (CRPC).
Suárez C, Morales-Barrera R, Ramos V, Núñez I, Valverde C, Planas J, Morote J, Maldonado X, Carles J. Suárez C, et al. Among authors: planas j. BJU Int. 2014 Mar;113(3):367-75. doi: 10.1111/bju.12110. Epub 2013 Apr 12. BJU Int. 2014. PMID: 23650874 Free article. Review.
The present and future of prostate cancer urine biomarkers.
Rigau M, Olivan M, Garcia M, Sequeiros T, Montes M, Colás E, Llauradó M, Planas J, Torres Id, Morote J, Cooper C, Reventós J, Clark J, Doll A. Rigau M, et al. Among authors: planas j. Int J Mol Sci. 2013 Jun 17;14(6):12620-49. doi: 10.3390/ijms140612620. Int J Mol Sci. 2013. PMID: 23774836 Free PMC article. Review.
[Holmium laser enucleation of the prostatic adenoma].
Placer J, López MA, Raventós C, Planas J, Salvador C, Ropero J, Morote J. Placer J, et al. Among authors: planas j. Arch Esp Urol. 2011 Apr;64(3):246-56. Arch Esp Urol. 2011. PMID: 21498890 Review. Spanish.
[Biochemical recurrence criteria after radical prostatectomy. Natural history of the disease].
Planas J, Morote J. Planas J, et al. Arch Esp Urol. 2012 Jan-Feb;65(1):4-11. Arch Esp Urol. 2012. PMID: 22318173 Review. Spanish.
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback